Medtronic plc
$83.14
▲
1.4%
2026-04-22 10:12:13
www.medtronic.com
NYQ: MDT
Explore Medtronic plc stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$107.11 B
Current Price
$83.14
52W High / Low
$106.33 / $79.93
Stock P/E
23.25
Book Value
$38.17
Dividend Yield
3.34%
ROCE
8.3%
ROE
9.39%
Face Value
—
EPS
$3.58
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
95,000
Beta
0.76
Debt / Equity
57.06
Current Ratio
2.54
Quick Ratio
1.42
Forward P/E
14.38
Price / Sales
3.16
Enterprise Value
$131.87 B
EV / EBITDA
13.97
EV / Revenue
3.72
Rating
Buy
Target Price
$109.64
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 2. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 3. | AVITA Medical, Inc. | $5 | — | $157.45 M | — | 676.75% | 799.72% | $10.29 / $3.22 | $-0.55 |
| 4. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 5. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 6. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 7. | 908 Devices Inc. | $7.3 | 13.73 | $267.64 M | — | -16.46% | -25.77% | $9.34 / $4.2 | $3.96 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 9.02 B | 8.96 B | 8.58 B | 8.93 B | 8.29 B | — |
| Operating Profit | 1.6 B | 1.7 B | 1.52 B | 1.8 B | 1.71 B | — |
| Net Profit | 1.14 B | 1.37 B | 1.04 B | 1.06 B | 1.29 B | — |
| EPS in Rs | 0.89 | 1.07 | 0.81 | 0.82 | 1.01 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 33.54 B | 32.36 B | 31.23 B | 31.69 B |
| Operating Profit | 6.54 B | 5.52 B | 5.83 B | 5.91 B |
| Net Profit | 4.66 B | 3.68 B | 3.76 B | 5.04 B |
| EPS in Rs | 3.63 | 2.86 | 2.93 | 3.92 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 91.68 B | 89.98 B | 90.95 B | 90.98 B |
| Total Liabilities | 43.42 B | 39.56 B | 39.28 B | 38.26 B |
| Equity | 48.02 B | 50.21 B | 51.48 B | 52.55 B |
| Current Assets | 23.81 B | 21.93 B | 21.68 B | 23.06 B |
| Current Liabilities | 12.88 B | 10.79 B | 9.05 B | 12.39 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 7.04 B | 6.79 B | 6.04 B | 7.35 B |
| Investing CF | -1.94 B | -2.37 B | -3.49 B | -1.66 B |
| Financing CF | -4.36 B | -4.45 B | -4.96 B | -5.34 B |
| Free CF | 5.18 B | 5.2 B | 4.58 B | 5.98 B |
| Capex | -1.86 B | -1.59 B | -1.46 B | -1.37 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 3.62% | 3.64% | -1.45% | — |
| Earnings Growth % | 26.82% | -2.18% | -25.42% | — |
| Profit Margin % | 13.9% | 11.36% | 12.03% | 15.9% |
| Operating Margin % | 19.5% | 17.06% | 18.67% | 18.65% |
| Gross Margin % | 65.32% | 65.34% | 65.67% | 67.98% |
| EBITDA Margin % | 27.49% | 25.35% | 27.85% | 27.7% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-27 | $0.71 |
| 2025-12-26 | $0.71 |
| 2025-09-26 | $0.71 |
| 2025-06-27 | $0.71 |
| 2025-03-28 | $0.7 |
Stock Splits
No stock split history available.